Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2019.397 | Molecular Epidemiology of Hepatitis E Virus Genotype Distribution in Hong Kong |
Dr. CHAN Chi Wai 陳子蔚 |
| 2019.417 | Glycans, oysters and the gut microbiota in enteric viruses transmission and dominance |
Dr. CHAN Chi Wai 陳子蔚 |
| 2019.446 | Generation of host genetic factor information known to associate with hospitalized severe influenza |
Dr. CHAN Chi Wai 陳子蔚 |
| 2019.187 | Molecular surveillance of norovirus gastroenteritis in Hong Kong |
Dr. CHAN Chi Wai 陳子蔚 |
| 2014.410 | End-of-life decisions in Neonatal Intensive Care Unit: A Retrospective Analysis of Modes of Deaths in the NICU | Dr Chan Chi Ngong, Lawrence |
| 2014.651 | Symptom prevalence, bother and treatment satisfaction in men with lower urinary tract symptoms in Southeast Asia: A multinational, cross-sectional survey | Dr. CHAN Chi Kwok |
| 2013.539 | The relationship between treatment for persistent nocturia in men following transurethral prostate surgery by Desmopressin Acetate Sublingual Wafer Oral Disintegration Formulation (Minirin Melt® 60 μg) and improvement of sleep quality | Dr. CHAN Chi Kwok |
| 2009.341 | The Discriminant Power of a Disposable Low-Cost Plastic Home-Based Uroflowmeter in Identifying New Territories East (NTE) Male Patients Having Lower Urinary Tract Symptoms (LUTS) with Low Micturition Flow Rate | Dr. Chan Chi Kwok |
| 2007.491 | The Effect of Proprioceptive Training in the Reduction of ACL Injury of Hong Kong Professional Soccer Teams | Mr Chan Chi Kit |
| 2008.555 | Evaluation the effects of post-exercise static stretching on the change and recovery rate in tissue oxygenation and haemoglobin level of quadriceps after short sprint cycling by using near infrared spectroscopy (NIRS). A cross-over study | Mr. Chan Chi Fung |
| 2018.079 | "Social Impairment and Social Inappropriate Behavior in Patients with First Episode Psychosis: A Caregivers’ perspective” |
Mr. CHAN Cheuk Yin 陳卓賢 |
| 2012.262 | Prevalence of psychiatric morbidity in Chinese subjects with gender identity disturbances in Hong Kong | Dr Chan Cheuk Chi |
| 2024.391 | Predictors of long-term inappropriate Proton Pump Inhibitor use in the Elderly | Dr. CHAN Chak Hei |
| 2024.018 | Effectiveness of multi-media genetic counselling method and the factors influencing the decision-making process for breast cancer genetic testing | Prof. CHAN Carmen WH |
| 2024.148 | The conflict status of fertility preservation decision-making and their impacts on decision results in childbearing-age female patients with cancer | Prof. CHAN Carmen W.H. |
| 2008.115 | A Pilot Study to Assess the Feasibility and Acceptability of Using the Electronic Self Report Assessment - Cancer (ESRA-c) amongst Chinese Oncology Patients | Prof Chan Carmen W.H. |
| 2016.321 | Early-life gut microbiome and environmental factors in the development of eczema in Chinese children: a birth cohort study |
Prof. CHAN Carmen W.H. 陳葉詠嫻 |
| 2016.554 | Advancing the science of personalized health care: A prospective study to uncover the role of predictive biomarkers in tamoxifen-related endocrine symptoms and drug adherence based on genetic polymorphisms in breast cancer patients in Hong Kong |
Prof. CHAN Carmen W.H. 陳葉詠嫻 |
| 2016.560 | Hong Kong Nurses perceptions of optimal end of life care in hospitals |
Prof. CHAN Carmen W.H. 陳葉詠嫻 |
| 2008.220 | A Survey on Health Status of Childhood Cancer Survivors | Prof Chan Carmen W.H. |
| 2010.182 | A conceptual model of self-care and symptom management following cancer treatment for Hong Kong Chinese | Prof Chan Carmen W.H. |
| 2013.133 | Developing a conceptual model to predict the acceptance and completion of advance directives in the Chinese community in Hong Kong: A population-based survey | Prof. CHAN Carmen W. H. |
| 2007.374 | Quantitative assessment of optic disc morphology of non-glaucomatous optic neuropathy | Dr. CHAN Carmen Kar Mun |
| 2023.359 | A multimedia method for pre-test genetic counseling in breast cancer patients – A pilot feasibility study | Prof. CHAN Carmen |
| 2015.628 | Neonatal Behavioral Differences on Newborn Babies |
Ms. CHAN Barbara Chung Man 陳頌文 |
| 2016.449 | To understand the attitudes of the public, patients receiving palliative care, their relatives and health professionals towards using Traditional Chinese Medicine treatment in Hong Kong Palliative care. |
Miss CHAN Audrey Ho Yan 陳可昕 |
| 2024.268 | Single shot thoracic paravertebral block (TPVB) with dextran and magnesium compared to continuous TPVB in unilateral rib fracture - a randomised controlled non-inferiority trial | Dr. Chan Anyon |
| 2016.278 | Functional role of the gluconeogenesis regulatory enzyme, fructose-1,6-bisphosphatase-1 (FBP1), in hepatocarcinogenesis |
Dr. CHAN Anthony Wing Hung 陳永鴻 |
| 2016.496 | CCCTC-binding factor (CTCF) in hepatocellular carcinoma: functional characterization of its role in tumorigenesis and its potential in targeted therapy. | Dr. CHAN Anthony Wing Hung |
| 2009.572 | Clinical significance of the metastasis-associated protein osteopontin in naopharyngeal cancer | Professor Chan Anthony TC |
| 2004.024 | Identification of Serum Prognostic Proteomic Patterns in Nasopharyngeal Carcinoma Development of Clinical Assay Prototype with the Combined Use of SELDI-TOF Mass Spectrometry and Bioinformatic Analyses | Prof. CHAN Anthony TC |
| 2014.409 | An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Prof. CHAN Anthony Tak Cheung |
| 2016.382 | Detection and isolation of circulating tumor cells from patients with nasopharyngeal carcinoma. |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2016.070 | A Two-arm, Open-label, Randomized Phase III Study of Pembrolizumab (MK-3475) Monotherapy versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122) |
Prof. CHAN Anthony Tak Cheung 陳德章敎授 |
| 2010.396 | A Proposed Histological Classification of Nasopharyngeal Carcinoma Based on Epithelial-Messenchymal Transition and Its Significance in Prognosis Prediction | Prof. Chan Anthony Tak Cheung |
| 2018.372 | NEO-SPACE trial: Neoadjuvant Pembrolizumab-Gemcitabine-Cisplatin followed by Concurrent Pembrolizumab-Chemoradiation and Maintenance Pembrolizumab for Stage IVA Nasopharyngeal Cancer |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2019.553 | AXEL: Axitinib-Avelumab combination in recurrent or metastatic nasopharyngeal cancer: a multicenter phase 2 trial |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2013.295 | LUX-Head & Neck 3: A randomized, open label, phase III study to evaluate the efficacy and safety of oral afatinib (BIBW 2992) versus intravenous methotrexate in patients with recurrent and / or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy. | Prof. CHAN Anthony Tak Cheung |
| 2000.447 | Pre and Post-Operative Chemotherapy with Oxaliplatin 5FU/LV Versus Surgery Alone in Resectable Liver Metastases from Colorectal Origin Phase III Randomized Study | Prof. CHAN Anthony T.C. |
| 2008.198 | A Phase 2, Randomized Trial of Chemoradiation with or without Panitumumab in Subjects with Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck | Prof. CHAN Anthony T.C. |
| 2019.001 | Survival analysis of germline polymorphism and prognosis of patients with NPC |
Prof. CHAN Anthony T.C. 陳德章 |
| 2007.198 | A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer | Prof. CHAN Anthony T. C. |
| 2006.024 | A Phase I Trial of 5-Azacitidine and Suberoylanilide Hydroxamic Acid in Patients with Metastatic or Locally Recurrent Nasopharyngeal Carcinoma and Nasal NK-T Cell Lymphoma | Prof. CHAN Anthony T. C. |
| 2008.203 | Phase II Study of TAS-106 in Patients with Recurrent or Metastatic Head and Neck Cancer Refractory to Platinum Based Chemotherapy | Prof. Chan Anthony |
| 2008.559 | Elucidating the role of the metastasis-associated SLBLING protein osteopontin in nasopharyngeal cancer | Prof Chan Anthony |
| 2010.253 | Phase 2 Study of Axitinib in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
| 2008.084 | Efficacy of Recombinant Epstein-Barr virus (EBV) Vaccine in Patients with Nasopharyngeal Cancer who had Residual EBV DNA Load after Conventional Therapy | Prof. CHAN Anthony |
| 2006.256 | Randomized Trial to Evaluate the Therapeutic Gain by Changing the Chemoradiotherapy from Concurrent-Adjuvant to Induction-Concurrent Sequence, and the Radiotherapy from Conventional to Accelerated Fractionation for Advanced Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
| 2005.414 | A Multi-Center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabline and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy with or without Concurrent Cisplatin | Prof. CHAN Anthony |
| 2016.472 | POOL-ANALYSIS OF INDUCTION CHEMOTHERAPY IN NASOPHARYNGEAL CARCINOMA |
Prof. CHAN Anthony 陳德章 |
Page 203 of 254.